Reinaldo N. Takahashi

Florianopolis, SC, Brazil

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications

Corrigendum to "Emotional, Cognitive and Neurochemical Alterations in a Premotor Stage Model of Parkinson's Disease" [Neuroscience 156(4) (2008) 830-840].

Corrigendum to "Emotional, Cognitive and Neurochemical Alterations in a Premotor Stage Model of Parkinson's Disease" [Neuroscience 156(4) (2008) 830-840].

Journal: Neuroscience
Published: November 28, 2021

Interactions of Noradrenergic, Glucocorticoid and Endocannabinoid Systems Intensify and Generalize Fear Memory Traces.

Interactions of Noradrenergic, Glucocorticoid and Endocannabinoid Systems Intensify and Generalize Fear Memory Traces.

Journal: Neuroscience
Published: June 15, 2021

From an Alternative Medicine to a New Treatment for Refractory Epilepsies: Can Cannabidiol Follow the Same Path to Treat Neuropsychiatric Disorders?

From an Alternative Medicine to a New Treatment for Refractory Epilepsies: Can Cannabidiol Follow the Same Path to Treat Neuropsychiatric Disorders?

Journal: Frontiers in psychiatry
Published: December 04, 2020

Ketamine reversed short-term memory impairment and depressive-like behavior in animal model of Parkinson's disease.

Ketamine reversed short-term memory impairment and depressive-like behavior in animal model of Parkinson's disease.

Journal: Brain research bulletin
Published: September 02, 2020

Temporal development of behavioral impairments in rats following locus coeruleus lesion induced by 6-hydroxydopamine: Involvement of β3-adrenergic receptors.

Temporal development of behavioral impairments in rats following locus coeruleus lesion induced by 6-hydroxydopamine: Involvement of β3-adrenergic receptors.

Journal: Neuropharmacology
Published: August 07, 2018

Caffeine and cannabinoid receptors modulate impulsive behavior in an animal model of attentional deficit and hyperactivity disorder.

Caffeine and cannabinoid receptors modulate impulsive behavior in an animal model of attentional deficit and hyperactivity disorder.

Journal: The European journal of neuroscience
Published: May 22, 2018

Early signs of colonic inflammation, intestinal dysfunction, and olfactory impairments in the rotenone-induced mouse model of Parkinson's disease.

Early signs of colonic inflammation, intestinal dysfunction, and olfactory impairments in the rotenone-induced mouse model of Parkinson's disease.

Journal: Behavioural pharmacology
Published: March 16, 2018

Cannabidiol as a Therapeutic Alternative for Post-traumatic Stress Disorder: From Bench Research to Confirmation in Human Trials.

Cannabidiol as a Therapeutic Alternative for Post-traumatic Stress Disorder: From Bench Research to Confirmation in Human Trials.

Journal: Frontiers in neuroscience
Published: December 28, 2017

Effects of Cannabinoid Drugs on Aversive or Rewarding Drug-Associated Memory Extinction and Reconsolidation.

Effects of Cannabinoid Drugs on Aversive or Rewarding Drug-Associated Memory Extinction and Reconsolidation.

Journal: Neuroscience
Published: March 20, 2017

Cannabidiol disrupts the consolidation of specific and generalized fear memories via dorsal hippocampus CB1 and CB2 receptors.

Cannabidiol disrupts the consolidation of specific and generalized fear memories via dorsal hippocampus CB1 and CB2 receptors.

Journal: Neuropharmacology
Published: March 16, 2017

Angiotensin II type 1/adenosine A 2A receptor oligomers: a novel target for tardive dyskinesia.

Angiotensin II type 1/adenosine A 2A receptor oligomers: a novel target for tardive dyskinesia.

Journal: Scientific reports
Published: January 12, 2017

Evidence for an expanded time-window to mitigate a reactivated fear memory by tamoxifen.

Evidence for an expanded time-window to mitigate a reactivated fear memory by tamoxifen.

Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published: June 17, 2016
Showing 1-12 of 36

Last Updated: 09/26/2026